BioMarin Pharmaceutical (NASDAQ: BMRN)
BioMarin Pharmaceutical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
BioMarin Pharmaceutical Company Info
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
News & Analysis
Investing in Biotech ETFs
Here are the five best biotech ETFs to invest in right now.
Why BioMarin Pharmaceuticals Fell 6.9% on Thursday
Investors were expecting better top-line numbers from the company's earnings report.
Why BioMarin Pharmaceutical Tumbled on Thursday
While the company broadly met expectations for the fourth quarter, investors seemed concerned about its 2022 guidance.
Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
The rare-disease specialist might now have a true franchise-level drug following the approval of Voxzogo.
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
The FDA is scheduled to announce these two key approval decisions in late November.
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
All it will take is an FDA approval and a partial repeat of history.
Is Now A Good Time To Buy BioMarin Stock?
Shares in this biotech company are down considerably from where they were this summer, but the stock looks ready to take off again.
2 Healthcare Stocks That Could Double Your Money
Patient investors could double their money in these two stocks that the market has temporarily cast aside.
Valuation
Earnings Transcripts
BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
BMRN earnings call for the period ending September 30, 2021.
BioMarin Pharmaceutical inc (BMRN) Q2 2021 Earnings Call Transcript
BMRN earnings call for the period ending June 30, 2021.
Biomarin Pharmaceutical Inc (BMRN) Q1 2021 Earnings Call Transcript
BMRN earnings call for the period ending March 31, 2021.
Biomarin Pharmaceutical Inc (BMRN) Q4 2020 Earnings Call Transcript
BMRN earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.